Cell-based and regenerative therapies include a broad range of approaches using autologous or donor-derived cells. They should not be presented as a single universal ‘stem cell therapy’: the cell type, manufacturing approach, indication and regulatory status must be specified. For neurological disorders, autism, epilepsy, spinal or brain injury, diabetes, gynecological and anti-aging programs, the website should clearly distinguish established care from clinical research.